The Delhi High Court has passed an interim order restraining Titan Laboratories Pvt Ltd from exporting generic of German drug maker Bayer’s blood thinner brand 'Xarelto' (rivaroxaban) for research and regulatory purposes. The judge has fixed September 14, 2020 as the next date of hearing.
Titan has teamed with Opiant to investigate skin implant technology in the administration of opioid antagonists over extended periods, to combat opioid relapse and overdose in outpatients.
Titan Laboratories Pvt Ltd. News Full Screen View
Market Place
Share